Tag: pharmaceuticals
-
NIH Stops Stem Cell Heart Failure Trial Over Retracted Data
National Heart, Lung, and Blood Institute, or NHLBI, part of the National Institutes of Health is suspending a clinical trial of stem cells to regenerate new heart muscle.
-
Gene Silencing Technology Licensed in $3.7B Deal
Dicerna Pharmaceuticals, developing treatments for disease that silence genes by interfering with their RNA instructions, is licensing its technology to drug maker Eli Lilly and Co
-
NVIDIA, Scripps Partner on Medical Deep Learning Applications
A high-performance computer chip maker and life science research center are collaborating on extending deep learning, a form of artificial intelligence, into more areas of medical science and practice.
-
Genome Editing, Informatics Lead to New Antibiotic
Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics.
-
NIH Supporting Electronic Neuro Drug Test Technology
A university spin-off enterprise is receiving funds from National Institute of Mental Health to develop a simple, reliable electronic device to evaluate effects of neurological drugs on brain cells.
-
Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments
Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis.
-
Diabetes Drug Assessed Long-Term Against All Other Treatments
A new clinical trial is testing the drug semaglutide for people with type 2 diabetes against as many as 40 other diabetes treatments when used as a supplemental drug over 2 years.
-
Antibody Designed to Stop Inflammation Protein in Brain
A synthetic antibody is shown in tests with lab mice to block the blood protein fibrin from causing inflammation and related damage to brain cells found in neurodegenerative diseases.
-
Cancer Antibody Trials Stopped After Patient Death
Two clinical trials testing synthetic antibodies designed to treat blood-related cancers were stopped by their developer after a participant in one trial died from adverse effects.
-
Prenatal Genome Edits Prevent Inherited Liver Disorder
Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder.